Neurofibromatosis Type 1-Associated Plexiform Neurofibromas
Pipeline by Development Stage
Drug Modality Breakdown
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (6)
Total enrollment: 259 patients across 6 trials
A Study of Mirdametinib in People With Central Nervous System Tumors
A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).
Mirdametinib + BGB-3245 in Advanced Solid Tumors
SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Individual Patient Compassionate Use of Mirdametinib
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.